Pharmaceutical Industry News Archive
Get news by email or subscribe to our news feeds.
News Archive for November 2009
November 2, 2009
- Amylin Pharmaceuticals and Eli Lilly and Company Statement on FDA's Byetta (Exenatide) Injection Update
- Byetta (exenatide) - Altered kidney function, including acute renal failure/renal insufficiency, in patients on Byetta
November 3, 2009
- Johnson & Johnson Announces Restructuring Initiatives for Sustainable Growth
- Connecticut Attorney General Writes Seasonal Flu Vaccine Makers, Distributors Regarding Alleged Price Gouging, Preferential Treatment
November 4, 2009
- New Merck Begins Operations Worldwide
- New Merck Begins Operations
- Nation?s Largest Nursing Home Pharmacy and Drug Manufacturer to Pay $112 Million to Settle False Claims Act Cases
November 5, 2009
- Sermo Launches the Practice Management Exchange to Support the New Physician Practice in a Changing Healthcare World
- Genmab Reorganizes to Build Sustainable Business
- Genmab Revises Financial Guidance
- IMS Health to be Acquired by TPG and CPP Investment Board
- IMS Health to be Acquired by TPG and CPP Investment Board
November 6, 2009
- Theravance and Astellas Announce the Commercial Launch of Vibativ (telavancin) in the United States
- Graceway Pharmaceuticals Acquires Worldwide Rights to GS 9191 from Gilead Sciences
November 9, 2009
- PhRMA Statement on House Passage of Health Care Reform Bill
- Computerized Support Keeps Prominence of Name Brand Drugs at Bay
- Covidien Submits Label Change for Optimark Contrast Agent
- Monsanto to Purchase Chesterfield Village Research Center From Pfizer
November 10, 2009
- Hospira Brand Propofol and Liposyn Products - Recall:Product containers may contain particulate matter that could act as emboli and lead to impeded blood flow
- Bristol-Myers Squibb and Alder Biopharmaceuticals Enter Global Agreement on Rheumatoid Arthritis Biologic
- PhRMA Statement About Accessing Online Health Information
- Basketball Legend Kareem Abdul-Jabbar Announces He Has Been Diagnosed With Chronic Myeloid Leukemia; Aims To Inspire Others
November 12, 2009
- Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain
- Action on Antipsychotic Drugs and Dementia
- Despite Some Benefit, Drug Ads Can Be Harmful to Your Health
- New Web Sites Educate About Triglycerides and HDL Cholesterol
November 13, 2009
- Astex Announces Strategic Drug Discovery Alliance with GlaxoSmithKline
- BioInvent Signs Licensing Agreement with Daiichi Sankyo for the Discovery and Development of Therapeutic Antibodies
- Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his Successor
- Drug Companies to Fight Neglected Diseases
- Eli Lilly Hires Paul as Chief Researcher
- Google Helps You Find A Flu Shot
- Cephalon, Barr Settle Fentora Dispute
- Google, Yahoo Call for Expanded Online Drug Ads
- Swiss OK Novartis Swine Flu Vaccine From Cells
- FDA Finds Bits of Steel, Rubber in Genzyme Drugs
November 14, 2009
- Merck Strengthens Its Commitment to Advancing Cardiovascular Health Care
- Genzyme Issues Letters to U.S. Healthcare Providers
November 16, 2009
- Bristol-Myers Squibb Announces Split-Off of Mead Johnson
- FDA Sends Warning Letters for Dacogen and Fosrenol
- Abbott Statement on ARBITER 6 - HALTS Results and Abbott's Niaspan (niacin extended-release)
- Particles Detected in Vials from Genzyme's Plant Not Expected to Impact Aldurazyme or Naglazyme
- Study Raises New Questions About Merck Pill Zetia
- Sanofi-Aventis Swine Flu Vaccine Cleared in France
- GlaxoSmithKline, Nabi to Develop Smoking Vaccine
- Boehringer Ingelheim Developing 'Female Viagra'
- Lilly's Big Cancer Bet: Seeking New Blockbusters
- Drug Industry Raises Prices by 9%
- Merck Announces Completion of Patient Enrollment in Phase III TRA-2°P-TIMI 50 Trial of SCH 530348, a Novel, Oral Antiplatelet PAR-1 Inhibitor
November 17, 2009
- Novartis: Lower Dose of Flu Vaccine Sufficient (AP)
- FDA Says Prilosec Can Block Benefits of Plavix
- Novartis: Lower Dose of Flu Vaccine Sufficient
- FDA Reviews Update to Pfizer Vaccine for Kids
- Genzyme Flops at FDA: Allston Plant Problems Delay Drug Review [Boston Herald]
- Drug Therapy More Cost-Effective Than Angioplasty for Diabetic Patients with Heart Disease, Stanford Researcher Finds
- Common Cold Virus May Have Foiled HIV Vaccine Test
- FDA and Everyday Health Collaborate to Expand Reach of Consumer Health Information
November 18, 2009
- FDA Says Heartburn Drugs Can Interfere with Plavix
- Vaccines on Horizon for AIDS, Alzheimer's, Herpes
- Pfizer Inc Submits New Pediatric Data for Lipitor to EMEA
- FDA Approves New Post-Shingles Attack Drug
- Pfizer Enters Tropical Disease Drug Partnership
- InterMune Shares Fall on Change in Hepatitis Study
- Ex-Pharma Executive Runs as Dem for Kansas Governor
November 19, 2009
- Genentech, Biogen Get FDA Request on Rituxan
- AstraZeneca Seeks Brilinta Approval in US
- FDA Panel Backs Pfizer's Enhanced Vaccine for Kids
- Committee Leaders Call for GAO Analysis of Recent Prescription Drug Price Increases
- Time to Blow Up the Pharmaceutical Sales Model? New Deloitte Debate
- PhRMA Statement on Misleading Reports About Price Growth
- FDA Issues 22 Warning Letters to Web Site Operators
- WHO: Swine Flu Shot Not Causing Deaths
- FDA Panel Backs Safety, Benefits of Spiriva
November 20, 2009
- Retiring Lilly Research Exec Steven Paul Gets $2 Million in Severance [The Indianapolis Star]
- Moody's Gives Negative View on Pharma Credit
- The Botax? Nip/Tuck Levy to Help Health Care Plan
- Antitrust Lawyer Files Suit to Stop Pfizer Merger
- Saatchi & Saatchi Wellness Names Russell as Managing Director
November 23, 2009
- Germany's Merck Will Expand R&D in China
- GlaxoSmithKline Calls for Suspension of New Flu Vaccinations in Canada
- FDA OKs Abilify for Autism-linked Irritability
- Tamiflu-resistant Swine Flu Cluster Reported in US
- Novartis Increases Staff Pay by 1.5% from April 2010
- FDA MedWatch - Meridia (sibutramine): Early Communication about cardiovascular events
- Merck KGaA to Expand Research and Development Presence in China
- Merck Claims Win in Texas Lawsuit Over Vioxx
- Congressional Documents and Publications
November 24, 2009
- Merck Wins Summary Judgment in Texas Attorney General's Lawsuit Involving Vioxx
- Merck Wins Summary Judgment in Second Federal Bellwether Case Involving Fosamax (alendronate sodium)
- Novartis: First US Plant for Cell-based Flu Vaccine
- Jury Awards $75 Million in Punitive Damages to Illinois Woman in Prempro Cancer Case
- Clavis Pharma and Clovis Oncology Sign $380 Million Partnership for the Development and Commercialisation of Anti-Cancer Agent CP-4126
- Novartis inaugurates large-scale US based cell-culture influenza vaccine manufacturing facility
- First US Plant for Cell-Based Flu Vaccines Opened
- Merck Says Key Fosamax Lawsuit Dismissed
- GlaxoSmithKline Pulls Application for New Drug Use
- Drug Ads Ineffective for Boosting Sales, Could Cost Taxpayers: UBC-Harvard Study
- Psychotropic Medications Associated With Risk of Falls in Older Adults
- Direct-to-consumer Ads Associated With Higher Medicaid Costs
- Gilead and GlaxoSmithKline Announce Agreement to Commercialize Viread for Chronic Hepatitis B in Key Asian Countries
- Pfizer Faces $103 Million in Prempro Damages
- Gilead Signs Sales Deal With Glaxo for Viread
November 25, 2009
- Idera Pharmaceuticals Announces Termination of Asthma and Allergy Research Collaboration Agreement
- Chugai Revises Corporate Advertisement for First Time in Four Years
- Idera Pharmaceuticals and Merck & Co., Inc. Extend Research Collaboration for Agonists of Toll-like Receptors as Vaccine Adjuvants
- SDI Reports: Prescriptions for Patients New to Niaspan Rise 41% in Week Following Release of Arbiter 6-HALTS Study Results
November 30, 2009
- EU Approves Single Dose Swine Flu Vaccine
- FDA OK's Agriflu Seasonal Flu Vaccine
- Hormone Boosts For Men Get A Test
- Sanofi Aventis Will Join Russian Drug Project
- Eyelash Drug Might Help Cancer Patients
- Theravance Says FDA Delays New Vitabiv Decision
- CEO: Bayer Will Not Shy Away From Major Acquisitions
- Consumers Pay Little or No Attention to Drug Company's Advertised Risk Disclosures, Latest Under the Skin Study from ORC Guideline Finds
- TheBody.com Launches My Health Tracker, Enabling HIV-Positive Patients to Track Lab Results, Medications and Supplements
